drugset
drugset / Trial / NCT02946021

Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema

NCT02946021 ↗

Phase 1/2 Completed 11 enrolled Tactile Medical
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Assessment of lymphatic structure and function pre- and post- treatment and during recovery in head and neck cancer related lymphedema patients using NIR fluorescence lymphatic imaging: Response to ICD therapy in HNC Patients.

Timeline

Start
2016-10
Primary completion
2018-02
Completion
2018-02

Drugs

EvaluationDrugModalityDoseRoute
Background Indocyanine Green Diagnostic / imaging agent — —

Indications

head and neck cancer lymphedema